O TYM ODCINKU

Język angielski
Stany Zjednoczone

TRANSKRYPCJA 🔗

WYSZUKAJ MINIONE ODCINKI

Wyszukaj minione odcinki ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research.

INNE ODCINKI W TYM PODCASCIE

The VESALIUS-CV trial demonstrated that the PCSK9 inhibitor evolocumab significantly reduced the risk of a first major cardiovascular event in patients with diabetes who had no known significant atherosclerosis. These findings challenge current clinical practice, where PCSK9 inhibitors are typicall…
ecent advancements in echocardiography since ACC.25 highlight a shift toward greater precision, efficiency, and consistency in cardiac imaging. Standardized echo reporting is now recognized as a key marker of quality care, improving communication and supporting more reliable clinical decisions, whi…
Randomized trials in stable ischemic heart disease (SIHD) show revascularization does not reduce death or myocardial infarction versus guideline-directed medical therapy, with benefit limited to symptom relief. This likely reflects lesion–ischemia mismatch, unclear ischemia origin, effective modern…
Cardiovascular protection during cancer treatment is critical to help prevent complications such as heart failure. Patients should be educated on risk factors, symptom awareness, and heart-healthy behaviors. Oncologists should incorporate cardiovascular risk assessment and surveillance into treatme…
Nonobstructive hypertrophic cardiomyopathy (HCM) represents one of the greatest areas of unmet need in HCM management. A key question is identifying the primary driver of symptoms in these patients, as many experience significant functional limitations despite the absence of left ventricular outflo…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z American College of Cardiology, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.